Industry news

• Q2 Global Forecast 2020 - The Economist

  09 April 2020 The Economist

  

  The Economist Intelligence Unit (EIU) expects that the global economy will contract by 2.5% in 2020 as a result of the coronavirus pandemic. This represents a much deeper global recession than that experienced during the global financial crisis.

• Russian Vaccine against COVID-19 Put on WHO List of Promising Vaccines

  09 April 2020 GMP News

  The St. Petersburg Research Institute of Vaccines and Sera of the Federal Medical Biological Agency said its vaccine against the novel coronavirus infection has been included in the list of promising vaccines of the World Health Organization (WHO). So far, this is the only Russian development on the WHO list.

• The Medicine Against RNA-dependent Viruses has Passed the First Phase of Clinical Trials

  08 April 2020 GMP News

  Scientists of the Center for Pharmaceutical and Chemical Technologies of Ural Federal University together with colleagues from the Institute of Organic Synthesis named after I. Ya. Postovsky UrB RAS synthesized and tested a drug effective against new strains of RNA-dependent viruses. The preliminary name of the drug is “Triazide”. The drug has already passed preclinical trials and the first phase of a clinical study (healthy volunteers) and has shown efficacy and safety (in general, trials began in May 2016). 

• Regulatory Science Strategy to 2025 in the EU

  08 April 2020 GMP News

  EMA has published its Regulatory Science Strategy to 2025. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic acceleration of the pace of innovation in recent years and the need for regulators to be ready to support the development of increasingly complex human and veterinary medicines that combine different technologies. 

• A New COVID-19 Test System Began to Be Produced in Russia

  07 April 2020 GMP News

  Russia has registered a new test system for detecting the novel coronavirus (COVID-19) produced by the Russian company DNA Technology, the Russian Ministry of Industry and Trade reported.

• Care Access Research to Lead Clinical Trial of Breakthrough Coronavirus Test

  07 April 2020 GMP News

  Care Access Research, the leader in rapid development and management of high-performing clinical research sites, announced it is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.

• FDA Coordinates National Effort to Develop Blood Products for COVID-19

  06 April 2020 GMP News

  The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood. 

• Coronavirus Vaccines in Russia are Tested on Animals

  06 April 2020 GMP News

  Russia plans to begin preclinical coronavirus research on May 11, Director General of the Novosibirsk-based Vector State Research Center of Virology and Biotechnology Rinat Maksyutov told reporters.

• EMA: Chloroquine only to Be Used in Clinical Trials or Emergency Use Programmes

  03 April 2020 GMP News

  Chloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are being investigated worldwide for their potential to treat coronavirus disease (COVID-19). However, efficacy in treating COVID-19 is yet to be shown in studies.

• Pre-clinical Trials of the Russian Vaccine’s Specific Activity Will Be Held before June 22

  03 April 2020 GMP News

  Russia will complete pre-clinical trials of the vaccines against the novel coronavirus (COVID-19) developed at the Vector State Research Center of Virology and Biotechnology in Novosibirsk before June 22, Russian Deputy Prime Minister Tatyana Golikova said during a video call between Russian President Vladimir Putin and the Russian government.